Clinical Trial Update: Study Evaluating the Efficacy of a Double Immunotherapy Combined With Olaparib in Patients With Solid Cancers and Carriers of Homologous Recombination Repair Genes After Olaparib Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a double immunotherapy combined with olaparib in solid cancers for patients with homologous recombination repair gene alterations after…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Cancers

Drugs mentioned

• Double immunotherapy
• Olaparib (Olaparib)

Snippet

Sponsor: Centre Georges Francois Leclerc | Conditions: Immunotherapy | Phase 2 | Status: ACTIVE_NOT_RECRUITING